JP2011511075A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011511075A5 JP2011511075A5 JP2010545891A JP2010545891A JP2011511075A5 JP 2011511075 A5 JP2011511075 A5 JP 2011511075A5 JP 2010545891 A JP2010545891 A JP 2010545891A JP 2010545891 A JP2010545891 A JP 2010545891A JP 2011511075 A5 JP2011511075 A5 JP 2011511075A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- unsubstituted
- alkoxy
- phenyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc1c(CCN2CCOCC2)c2cc(**)ccc2[n]1C(c(cccc1Cl)c1Cl)=O Chemical compound Cc1c(CCN2CCOCC2)c2cc(**)ccc2[n]1C(c(cccc1Cl)c1Cl)=O 0.000 description 5
- JZCPYUJPEARBJL-UHFFFAOYSA-N Cc1c(-c(cc2)ccc2Cl)[n](-c(c(Cl)c2)ccc2Cl)nc1C(NN1CCCCC1)=O Chemical compound Cc1c(-c(cc2)ccc2Cl)[n](-c(c(Cl)c2)ccc2Cl)nc1C(NN1CCCCC1)=O JZCPYUJPEARBJL-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6508908P | 2008-02-08 | 2008-02-08 | |
| US61/065,089 | 2008-02-08 | ||
| PCT/US2009/000810 WO2009099670A2 (en) | 2008-02-08 | 2009-02-06 | Oligomer-cannabinoid conjugates |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011511075A JP2011511075A (ja) | 2011-04-07 |
| JP2011511075A5 true JP2011511075A5 (cg-RX-API-DMAC10.html) | 2013-01-31 |
| JP5704925B2 JP5704925B2 (ja) | 2015-04-22 |
Family
ID=40602328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010545891A Expired - Fee Related JP5704925B2 (ja) | 2008-02-08 | 2009-02-06 | オリゴマー−カンナビノイドコンジュゲート |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US8829043B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2254601B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP5704925B2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2009099670A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2254601B1 (en) | 2008-02-08 | 2019-05-29 | Nektar Therapeutics | Oligomer-cannabinoid conjugates |
| WO2011006099A1 (en) * | 2009-07-10 | 2011-01-13 | Northeastern University | Angiogenic resorcinol derivatives |
| US10220020B2 (en) | 2010-12-23 | 2019-03-05 | Nektar Therapeutics | Polymer-des-ethyl sunitinib conjugates |
| EP2654799B1 (en) | 2010-12-23 | 2017-11-08 | Nektar Therapeutics | Polymer-sunitinib conjugates |
| BR112015007578B1 (pt) | 2012-10-02 | 2020-05-05 | Bayer Cropscience Ag | Uso não terapêutico de compostos, compostos, composições emétodo não terapêutico para controlar pragas compreendendoos referidos compostos |
| CA3046638A1 (en) * | 2016-11-11 | 2018-05-17 | Bennes, Inc. | Formulations for efficient delivery of cannabinoids |
| EP3600361A4 (en) | 2017-03-24 | 2021-01-06 | Trait Biosciences, Inc. | High level in vivo biosynthesis and isolation of water-soluble cannabinoids in plant systems |
| CA3069178A1 (en) | 2017-07-11 | 2019-01-17 | Trait Biosciences, Inc. | Generation of water-soluble cannabinoid compounds in yeast and plant cell suspension cultures and compositions of matter |
| US11905543B2 (en) | 2017-07-11 | 2024-02-20 | Trait Biosceinces, Inc. | In vivo generation of water-soluble acetylated cannabinoid glycoside compounds in plant cell suspension cultures |
| US11946059B2 (en) | 2017-07-11 | 2024-04-02 | Trait Biosciences, Inc. | In vivo generation of water-soluble cannabinoids in plant cell suspension cultures |
| EP3959193A4 (en) * | 2019-05-23 | 2022-07-13 | Kare Chemical Technologies Inc. | Catalytic cannabinoid processes and precursors |
| US12257307B2 (en) | 2019-06-24 | 2025-03-25 | Diverse Biotech, Inc. | β-lactam-cannabinoid conjugate molecules |
| WO2020263888A1 (en) * | 2019-06-24 | 2020-12-30 | Diverse Biotech, Inc. | Cannabinoid conjugate molecules |
| US12485181B2 (en) * | 2019-06-28 | 2025-12-02 | Serina Therapeutics (Al), Inc. | Polyoxazoline-drug conjugates with novel pharmacokinetic properties |
| CN110372627B (zh) * | 2019-07-04 | 2022-12-06 | 南昌大学 | 一种1,3,4-噁二唑衍生物及其制备方法和应用 |
| JP2022552373A (ja) * | 2019-10-15 | 2022-12-15 | ダイヴァース バイオテック， インコーポレイテッド | コンジュゲート分子 |
| WO2021138540A1 (en) | 2020-01-03 | 2021-07-08 | Berg Llc | Polycyclic amides as ube2k modulators for treating cancer |
| US12491199B2 (en) | 2020-04-17 | 2025-12-09 | University Of Connecticut | Polycannabinoids, compounds, compositions and methods of use |
| CN112592260A (zh) * | 2020-11-30 | 2021-04-02 | 云南苏理生物医药科技有限公司 | 一种大麻二酚的合成方法 |
| IL313450A (en) * | 2021-12-09 | 2024-08-01 | Kare Chemical Tech Inc | Catalytic synthesis of tetrahydrocannabinol and starting materials |
| CN115784836A (zh) * | 2022-12-08 | 2023-03-14 | 南京康立瑞生物科技有限公司 | 一种高选择性的制备反式-薄荷基-2,8-二烯-1-醇的方法 |
| WO2025034533A1 (en) | 2023-08-04 | 2025-02-13 | University Of Connecticut | Natural and synthetic cannabinoids as fluorescent tags; compositions, methods, and applications |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3968125A (en) | 1973-11-05 | 1976-07-06 | Eli Lilly And Company | Dihydroxyhexahydrodibenzo[b,d]pyrans |
| AU8763275A (en) * | 1975-01-13 | 1977-06-23 | Abbott Lab | Tri-cyclic compounds derived from phloroglucinol |
| GB1522057A (en) * | 1975-11-03 | 1978-08-23 | Pfizer | 9-hydroxydibenzo(b,d)pyrans and intermediates therefor |
| HU194858B (en) * | 1982-12-03 | 1988-03-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them |
| FR2692575B1 (fr) | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| US5532237A (en) | 1995-02-15 | 1996-07-02 | Merck Frosst Canada, Inc. | Indole derivatives with affinity for the cannabinoid receptor |
| US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
| FR2741621B1 (fr) * | 1995-11-23 | 1998-02-13 | Sanofi Sa | Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant |
| WO2001003668A1 (en) | 1999-07-08 | 2001-01-18 | Her Majesty The Queen As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government | Pulmonary delivery of liposome-encapsulated cannabinoids |
| US6835802B2 (en) | 2001-06-04 | 2004-12-28 | Nobex Corporation | Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties |
| EA200500475A1 (ru) * | 2002-09-09 | 2005-10-27 | Нектар Терапеутикс Ал, Корпорейшн | Водорастворимые полимерные алканалы |
| PL377778A1 (pl) | 2002-12-02 | 2006-02-20 | Astellas Pharma Inc. | Pochodne pirazolu |
| FR2854896B1 (fr) * | 2003-05-16 | 2007-08-17 | Mayoly Spindler Lab | Nouveaux tensioactifs, compositions les comprenant |
| NZ594834A (en) | 2003-12-16 | 2013-03-28 | Nektar Therapeutics | Method of preparing PEGylated protein molecules |
| JP2006316054A (ja) | 2005-04-15 | 2006-11-24 | Tanabe Seiyaku Co Ltd | 高コンダクタンス型カルシウム感受性ｋチャネル開口薬 |
| JP5069894B2 (ja) * | 2005-10-21 | 2012-11-07 | 田辺三菱製薬株式会社 | ピラゾール化合物 |
| EP1951678A1 (en) * | 2005-10-21 | 2008-08-06 | Mitsubishi Tanabe Pharma Corporation | Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity |
| CA2694325C (en) * | 2007-07-30 | 2015-09-22 | Alltranz Inc. | Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| DK2215071T3 (en) * | 2007-11-30 | 2015-10-05 | Zynerba Pharmaceuticals Inc | Prodrugs of tetrahydocannabinol, compositions containing prodrugs of tetrahydrocannabinol, as well as methods of use thereof |
| EP2254601B1 (en) | 2008-02-08 | 2019-05-29 | Nektar Therapeutics | Oligomer-cannabinoid conjugates |
-
2009
- 2009-02-06 EP EP09708118.6A patent/EP2254601B1/en active Active
- 2009-02-06 WO PCT/US2009/000810 patent/WO2009099670A2/en not_active Ceased
- 2009-02-06 JP JP2010545891A patent/JP5704925B2/ja not_active Expired - Fee Related
- 2009-02-06 US US12/865,372 patent/US8829043B2/en active Active
-
2014
- 2014-07-22 US US14/338,111 patent/US9155797B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011511075A5 (cg-RX-API-DMAC10.html) | ||
| JP2011500545A5 (cg-RX-API-DMAC10.html) | ||
| CZ228295A3 (en) | The use of carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation | |
| WO2007082808A3 (en) | Thiazoles as 11 beta-hsd1 inhibitors | |
| WO2005117890A3 (en) | Thienopyrimidines and thiazolopyrimidines for use in medicine | |
| JP2009536933A5 (cg-RX-API-DMAC10.html) | ||
| JP2008195730A5 (cg-RX-API-DMAC10.html) | ||
| JP2016520618A5 (cg-RX-API-DMAC10.html) | ||
| WO2012018534A3 (en) | Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases | |
| MX2009009473A (es) | Compuestos para el tratamiento de hepatitis c. | |
| WO2009010416A3 (en) | Inhibitors of 11b-hydroxysteroid dehydrogenase | |
| JP2009536620A5 (cg-RX-API-DMAC10.html) | ||
| JP2012533546A5 (cg-RX-API-DMAC10.html) | ||
| JP2006501201A5 (cg-RX-API-DMAC10.html) | ||
| JP2010527913A5 (cg-RX-API-DMAC10.html) | ||
| JP2009523777A5 (cg-RX-API-DMAC10.html) | ||
| JP2010539179A5 (cg-RX-API-DMAC10.html) | ||
| DE602008001725D1 (de) | 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus | |
| MX2008002061A (es) | Derivados de tiazolil piperidina utiles como moduladores del receptor h3. | |
| ATE528306T1 (de) | Benzoxazepin-verbindungen, ihre herstellung und verwendung | |
| JP2011526247A5 (cg-RX-API-DMAC10.html) | ||
| JP2013506674A5 (cg-RX-API-DMAC10.html) | ||
| JP2009541387A5 (cg-RX-API-DMAC10.html) | ||
| WO2008039406A3 (en) | Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist | |
| CA2382247A1 (en) | Azaindoles having serotonin receptor affinity |